Abu Dhabi:Sheikh Shakhbout Medical City (SSMC), a flagship hospital in the UAE, has been ranked among the world's best hospitals for oncology in Newsweek's World's Best Specialized Hospitals 2027 rankings, securing the second position in the UAE and 219th globally.
According to Wam, this accolade highlights SSMC's growing reputation in specialized oncology care both regionally and globally. It emphasizes the hospital's commitment to providing care that meets the highest international standards. The placement in Newsweek's rankings reflects the strength of SSMC’s integrated model for complex and personalized cancer care.
The recognition also honors the collaborative efforts of SSMC's medical, nursing, technical, and administrative teams, who are dedicated to delivering comprehensive cancer care. This follows SSMC's recent Magnet Recognition from the American Nurses Credentialing Center, which acknowledges nursing excellence and enhances patient trust in the quality and safety of care provided.
SSMC is distinguished by its broad expertise in medical, surgical, and radiation oncology, haematology, advanced imaging, molecular diagnostics, and precision medicine. It offers a wide range of treatments including chemotherapy, immunotherapy, advanced radiation therapy, and minimally invasive interventional oncology procedures. This integrated approach ensures that specialists can tailor diagnosis and treatment to the individual needs of patients, including those with rare and complex cancers.
Newsweek's rankings, developed in collaboration with Statista, are highly regarded international benchmarks that highlight clinical expertise and offer an independent measure of institutional standing globally. These rankings cover 13 medical fields and are based on international peer recognition and hospital accreditations.
Dr. Marwan Al Kaabi, CEO of SSMC, expressed that being ranked among the world's best hospitals for oncology is a testament to the expertise developed by their teams and the advanced model of cancer care they are promoting. He emphasized the importance of multidisciplinary expertise, precision medicine, and advanced technology in providing highly specialized care in Abu Dhabi, offering patients and families greater choices closer to home.
SSMC's oncology model is supported by its academic and research infrastructure, integrating clinical practice with education and research. The hospital is accredited by the Joint Commission International (JCI) and is the first in the UAE to achieve JCI Academic Medical Centre status, underscoring its commitment to excellence in clinical care, education, and research.
Research is a core component of SSMC's approach to enhancing patient care, with its Clinical Trials Unit conducting various studies in oncology and haematology. Eligible patients have the opportunity to participate in research evaluating new treatments and methodologies under established scientific and ethical guidelines.
This recognition further solidifies SSMC's role in enhancing access to advanced oncology care in Abu Dhabi and contributing to the emirate's standing as a hub for specialized healthcare.